---
$id: https://graph.org.ai/products/commodity/51271914
$type: Product
source: UNSPSC
code: "51271914"
title: "Propoxycaine"
class: "51271900"
classTitle: "Anaesthetic aminobenzoates"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Propoxycaine

**UNSPSC Code**: 51271914
**Class**: [Anaesthetic aminobenzoates](Anaesthetic aminobenzoates.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C16H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EPD1EH7F53, chemically known as 4-amino-2-propoxybenzoic acid, 2-(diethylamino)ethyl ester but generally known as propoxycaine, which bears US NIH Compound Identifier 6843. European Medicines Agency schedules Propoxycaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10118MIG. The term PROPOXYCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). PROPOXYCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule propoxycaine under HS 29225000 and SITC 51467. As of Q4 2014, PROPOXYCAINE remains the US FDA Preferred Term for this commodity. Propoxycaine bears US NLM identifiers UMLS ID C0033492 and NCI Concept Code C66492. SMILES: O(CCN(CC)CC)C(=O)C1C(OCCC)CC(N)CC1.

